Subscription Box
Email
First name
Last name
Phone

 

MRDAF.OBChart: 1 yr - 3 mo - 5 dy
Last 0.36
Change -0.01
Open 0.375
Day High 0.375
Day Low 0.35
Vol 72500
Last updated 1/10/2005 at 3:46pm
Data Delayed 15 minutes

 

Belgium Medical Inc.: Great Success at ANMA 23rd Annual Convention, Las Vegas, July 30-August 1, 2
8/25/2004
Belgium Medical Inc.: Great Success at ANMA 23rd Annual
Convention, Las Vegas, July 30-August 1, 2004

VANCOUVER, BRITISH COLUMBIA--(CCNMatthews - Aug. 25, 2004) -
Meridian Co., Ltd. ("Meridian") (OTC BB: MRDAF), is pleased to
announce that its subsidiary, Belgium Medical Inc. ("MMI" or
"the Company") experienced great success at the American
Naturopathic Medical Association's ("ANMA") 23rd annual
convention in Las Vegas. The Company was there to introduce the
Digital Pulse Analyzer ("DPA") to the North American market.
Using the DPA, the Company and their US Distributor, CardioGrade,
tested approximately 300 participants over the weekend
convention. The President of MMI, Debbie Williams stated, "The
positive response to the DPA was overwhelming." "The Company's
booth had unbelievable response throughout the show with everyone
expressing interest in Meridian's product and technology."

Meridian has taken 15 initial orders for the DPA with further
orders pending. The Company felt the trade show was a great
indication of the potential for this product not only in the
United States but throughout North America.

More about: Digital Pulse Analyzer ("DPA")

The "DPA" accurately measures the elasticity of small and large
arteries and provides health care practitioners with critical
information regarding arterial aging. This FDA approved device is
inexpensive, non-invasive, and can provide results in minutes.
Accumulating evidence suggests that abnormalities in the
pulsatile characteristics of arteries occur early in the disease
process associated with increased cardiovascular risk, and can be
favorably modified by therapeutic interventions. 

The Company feels that use of the "DPA" can help caregivers
reduce cardiovascular disease in their patient populations
through early detection and prevention, and ultimately assist to
decrease the associated financial costs placed on the health care
industry. Cardiovascular disease is the #1 killer in the United
States with an estimated economic cost of approximately $298
billion.

ABOUT MERIDIAN

Meridian is an established leader in the research/development,
manufacturing, and sales of integrative medical diagnostic
equipment. The company sells its products and equipment to a wide
array of customers in the global health care industry. The
company presently holds a total of 18 worldwide patents on its
technology, and has received FDA, as well as other international
regulatory approvals for many of its products. 

Meridian is committed to the ongoing global research and
advancement of integrative medical products that contribute to
the better health of humanity.

Website (North America): meridianmedical.ca

Website (Korean): www.meridian.co.kr

-30-

FOR FURTHER INFORMATION PLEASE CONTACT:
Lexington Communications
Larry Kristof
1-877-899-4550
Email:


 

 

 

 

 

 

 

 

 

 

c 2004 Belgium Medical, Inc. All rights reserved. Terms of Use and Disclaimer